Pattern of Metastasis
in Cervical Lymph Nodes and Topographic Distribution of Primary Site: Study of
375 Case
Jetly D.1, Thummar S.
1Dr. Dhaval Jetly, Associate Professor and Head, 2Dr. Siddharth
Thummar, Resident Doctor; Both Authors are Attached with Pathology Department, Gujarat Cancer and Research Institute, Ahmedabad, India.
Corresponding Author: Dr. Siddharth Thummar, Resident Doctor, Pathology
Department, Gujarat Cancer and Research Institute, Ahmedabad, India. E-mail: siddharthkpatel@yahoo.co.in
Abstract
Introduction: Lymph nodes are the most common site of
metastatic malignancy and presence of metastatic tumor in lymph nodes is
essential for the management and prognosis of cancer. Cervical
lymph node metastasis most commonly develop from oral cavity malignancies.
Tumors of Upper Aerodigestive tract, Salivary and Thyroid glands and any other
sites of the body can present as cervical nodal metastasis. The
topographic correlations are helpful clues to the most common sites of origin
of metastases in cervical lymph nodes. Objectives: (1) Typing
of Metastatic Tumor, its Prevalence and Demographic Incidence in cervical lymph
nodes. (2) Distribution of Cervical lymph node metastasis & Relevance to
probable Primary Site. Methodology: In
the study, FNAC and/or Biopsy were taken from enlarged cervical lymph nodes to
confirm the metastatic tumor and to type the tumor. IHC was done whenever
necessary for diagnosis and to confirm the primary site. Relevant clinical
details and patient history were collected from patients’ case file and
electronic patients’ records. Total 375 malignant metastatic cases were
included in the study for analysis. Conclusion: SCC from head and neck region is the most
common metastatic malignancy present in the cervical lymph nodes. SCC from
Lung, Esophagus or Cervix can also present as metastatic lymph node.
Adenocarcinoma and Neuroendocrine carcinoma from Lung or GI Tract in Males
& Ductal Carcinoma of Breast and Papillary Thyroid Carcinoma in Females can
also involve Neck Lymph nodes.
Key
words: Cervical Lymph
node, Metastasis, Primary site, SCC
Author Corrected: 28th February 2019 Accepted for Publication: 5th March 2019
Introduction
Lymph nodes are the
most common site of metastatic malignancy and sometimes constitute the first
clinical manifestation of the disease. The task of the pathologist is to
identify the presence of a malignant process in the node, to establish whether
it is metastatic or not, andif, metastaticto provide an estimate of its amount,
microscopic type, and possible source. Establishing the presence of metastatic
tumor in lymph nodes is essential for the management and prognosis of cancer.
In solid tumors, lymph node status is the most important indicator of clinical
outcome [1].
Cervical lymph node metastasis most commonly
but, not always develop from oral cavity malignancies. Apart from oral
malignancies, squamous cell carcinoma of the upper Aerodigestive tract,
Salivary gland malignancies, Thyroid cancers and skin cancers of head and neck
region can present as cervical nodal metastasis. Cervical lymph nodes, particularly upper
jugular and posterior cervical nodes, drain the head and neck and may harbour
metastatic carcinomas originating in the Nasopharynx, Tonsillar fossa, Tongue,
Floor of the mouth, Thyroid, Extrinsic larynx, Facial skin, and Scalp. Scalene
lymph nodes representing the lower, deep jugular chain are commonly the site of
metastases from Intrathoracic carcinomas, particularly in the Lungs. The
supraclavicular lymph nodes are most often the site of metastases of Intra abdominal
cancers. The left supraclavicular lymph node, frequently invaded by Gastric
carcinoma and less commonly other Gastro intestinal tract carcinoma, is
classically known as the Virchow node. The topographic correlations are
helpful clues to the most common sites of origin of metastases in various
groups of regional lymph nodes [2].Besides all this, Infraclavicular
malignancies can also present as neck node metastasis.
Not infrequently, a lymph node metastasis is
discovered before an occult primary tumor is detected. In such cases, to identify
the Unknown primary tumor, extensive studies of the lymph node metastases,
including immunohistochemistry in addition to detailed histopathology, are
often necessary. It is estimated that 5 to 7% of cancer patients present with a
metastatic tumor of unknown origin [3,4].Carcinomas of the Nasopharynx and Oropharynx
are notorious for presenting with metastases in the cervical lymph nodes while
the primary neoplasm remains unnoticeable [5]. Sometimes tumors like base of
tongue or hypopharynx with local spread may present as nodal mass in neck and
finding of primary site is difficult clinically or radiologically. Not
uncommonly, the histologic pattern and cell morphology characteristic of a
tumor are no longer recognizable in its metastases. Identifying the primary
tumor may be difficult, often frustrating, yet indispensable for treatment. All
available methods of cytopathology, histopathology and immunohistochemistry
along with thorough clinico-radiological evaluation are required for typing and
subtyping of metastatic tumor.
Aims of This Study are
1)
Typing of Metastatic Tumor
and its Prevalence in Cervical Lymph Nodes.
2)
Demographic Incidence of
Metastatic Cervical Lymph Nodes.
3)
Distribution of Cervical
Lymph Node Metastasis & Relevance to probable Primary Site.
Material and methods
Type of study:
Prospective study
Sample Collection and Methods:The present study was conducted on patients present with
cervical lymph node enlargement during the period of one year.In the study,
FNAC and/or Biopsy were taken from enlarged cervical lymph nodes to confirm the
metastatic tumor and to type the tumor. For the further typing of tumor,
Immunohistochemistry was done whenever necessary.
Inclusion Criteria: All (n=375)
malignant metastatic cases of cervical lymph nodes were included in the study.
Patients with known and unknown primary tumor site were included.
Exclusion Criteria: Patients
with primary neoplasm of lymph node e.g. malignant lymphoma and Post-surgery
specimens of modified neck dissection in which lymph nodes are positive for
metastatic tumor were excluded.
Analysis: Out of
total 375 cases, FNAC was done on 137 cases and both FNAC and Biopsy were done
on 36 cases. Rest of the cases were confirmed by Biopsy. IHC was performed in
70 cases out of total 375 cases which could not be classified on histopathology
or primary sites of tumor was not known.
Relevant
clinical details and patient history were collected from patients’ case file
and electronic patients’ records. To determine primary site in cases of unknown
primary, radiological details were noted and Immunohistochemistry (IHC) was
performed on tissue blocks. All cytological, histological and/or Immunohistochemical
findings were noted and reviewed for morphological diagnosis.
Statistical Methods: Statistical
analysis was performed on collected data using standard statistical software
(SPSS).
Ethical Considerations: No
Ethical Issue related to the study.
In the Present Study, A Total of 375 consecutive
Cases having Metastatic Cervical Lymphadenopathy were Included for Analysis.
Table-1:
Demographic distribution of Metastatic Cervical Lymphadenopathy
Age Group |
Frequency |
Percentage |
0-20 |
8 |
2.13% |
21-40 |
41 |
10.93% |
41-60 |
200 |
53.33% |
61-80 |
121 |
32.27% |
81-100 |
5 |
1.33% |
Total |
375 |
100.00% |
Sex |
Males- 298 (79.47%) |
Females- 77 (20.53%) |
Table-2: Metastatic Pattern in Malignant
Cervical Lymph Nodes
Metastatic tumor |
Frequency |
Percentage |
Adenocarcinoma |
28 |
7.47% |
Anaplastic
carcinoma thyroid |
2 |
0.53% |
Ductal carcinoma
breast |
24 |
6.40% |
Germ cell tumor |
2 |
0.53% |
Granulocytic
sarcoma |
3 |
0.80% |
Nasopharyngeal
carcinoma |
4 |
1.06% |
Neuroendocrine
carcinoma |
20 |
5.33% |
Papillary
thyroid carcinoma |
9 |
2.40% |
Poorly
diffentiated carcinoma |
11 |
2.93% |
Squamous cell carcinoma |
262 |
69.87% |
Others* |
10 |
2.66% |
Total |
375 |
100.00% |
*Others include Epithelioid Sarcoma, High
grade Serous Carcinoma Ovary, Medullary Carcinoma Thyroid, Medulloblastoma,
Malignant Melanoma, PNET, RCC, Sarcomatoid Carcinoma, Spindle cell Sarcoma
Table-3: Distribution
of Metastatic Tumors in Females
Metastatic
tumor |
Frequency |
Percentage |
Adenocarcinoma |
5 |
6.49% |
Anaplastic
carcinoma thyroid |
2 |
2.60% |
Ductal carcinoma
breast |
24 |
31.17% |
Granulocytic
sarcoma |
2 |
2.60% |
Neuroendocrine
carcinoma |
2 |
2.60% |
Papillary thyroid
carcinoma |
7 |
9.09% |
Squamous cell
carcinoma |
31 |
40.26% |
Others* |
4 |
5.19% |
Total |
77 |
100.00% |
*Others include High grade Serous Carcinoma
Ovary, PDCA, PNET, Nasopharyngeal Undifferentiated Carcinoma
Table-4: Distribution
of Metastatic Tumors in Males
Metastatic
tumor |
Frequency |
Percentage |
Adenocarcinoma |
23 |
7.72% |
Germ cell tumor |
2 |
0.67% |
Nasopharyngeal
carcinoma |
3 |
1.00% |
Neuroendocrine
carcinoma |
18 |
6.04% |
Papillary thyroid
carcinoma |
2 |
0.67% |
Poorly
differntiated carcinoma |
10 |
3.36% |
Squamous cell
carcinoma |
231 |
77.52% |
Others* |
9 |
3.02% |
Total |
298 |
100.00% |
*others include epithelioid sarcoma, granulocytic sarcoma, medullary
carcinoma thyroid, medulloblastoma, malignant melanoma, PNET, RCC, sarcomatoid
carcinoma, spindle cell sarcoma
Table-5:
Distribution of Primary Site in Metastatic SCC
Primary site |
Frequency |
percentage |
Alveolus |
3 |
1.15% |
Angle of
mouth/lip |
2 |
0.76% |
Buccal mucosa |
37 |
14.12% |
Base of tongue |
34 |
12.98% |
Cervix |
4 |
1.53% |
Esophagus |
10 |
3.82% |
Eyelid |
1 |
0.38% |
Larynx |
54 |
20.61% |
Lung |
14 |
5.34% |
Maxilla |
4 |
1.53% |
Nasopharynx |
8 |
3.05% |
Oropharynx |
7 |
2.67% |
Palate |
5 |
1.91% |
Scalp ulcer |
1 |
0.38% |
Tongue |
19 |
7.25% |
Tonsil |
14 |
5.34% |
Unknown |
23 |
8.78% |
Vallecula |
22 |
8.40% |
Total |
262 |
100.00% |
Table-6:
Distribution of Primary Site in Metastatic Adenocarcinoma
Primary site |
Frequency |
Percentage |
Esophagus |
4 |
14.29% |
Gall bladder |
1 |
3.57% |
Lung |
15 |
53.57% |
Ovary |
3 |
10.71% |
Rectum |
2 |
7.14% |
Stomach |
3 |
10.71% |
Total |
28 |
100.00% |
Table-7: Distribution
of Primary Site in Metastatic Neuroendocrine Carcinoma
Primary site |
Frequency |
Percentage |
Esophagus |
1 |
5.00% |
Lung |
16 |
80.00% |
Mediastinal mass |
1 |
5.00% |
Pancreas |
1 |
5.00% |
Thymus |
1 |
5.00% |
Total |
20 |
100.00% |
Discussion
In the present
study, we analysed 375 cases of metastatic cervical lymph nodes confirmed by
FNAC and/or Biopsy.
Majority of the
cases were of age group 41-60 years i.e. 53% cases followed by age group 61-80
years i.e. 32% cases(Table-1). Age ranges were almost comparable to the study
done by Naresh et al[6], in which
most common age group was also 41-60 years i.e. 54% followed by 61-80 years
i.e. 25%.
Males were most
frequently involved in present study i.e. 80%.(Table-1) Most common secondary
malignancy found in cervical lymph node was squamous cell carcinoma i.e. 70% of
total metastatic tumors (Table-2) But in males, the percentage was higher i.e.
78% and in females, it was only 40%. After squamous cell carcinoma, most common
malignant metastatic tumor found was adenocarcinoma of lung i.e. 7% in males.
In females, most common malignant metastatic tumor found in cervical lymph
nodes after squamous cell carcinoma was ductal carcinoma breast i.e. 31%
followed by papillary carcinoma of thyroid i.e. 10% (Table 3,4)
Out of total 70%
cases of metastatic SCC, most common primary site was oral cavity i.e. 25%,
followed by pharynx i.e. 24% and larynx i.e. 21% cases. Lung and esophagus
squamous cell carcinoma are not uncommon. Rare primary sites were eyelid,
scalp, maxilla and cervix. (Table-5) In study by Candela et al[7], metastases were frequent in oral cavity tumors,
with a mean prevalence of 30.1 %. The corresponding figure for oropharyngeal
cancer was 10.3 %, largelybecause of the high prevalence in N + disease [7].
Out of total 8%
cases of metastatic adenocarcinoma i.e. 28 cases, most common primary site
found was lung in 54% cases followed by esophagus and ovary i.e. 15% and 11%
respectively. (Table-6) A study of 58 cases of remote metastasis in cervical
lymph nodes done by Wagh A[8]also
found 41% cases of lung metastasis in supraclavicular lymph nodes that is
comparable to present study. Davis
et al [9] reported the frequency of cervical lymph node involvement in
patients with lung cancer, to vary from 1.5% to 32%.
Out of total 5.3%
cases of neuroendocrine carcinoma i.e. 20 cases, most common primary site found
was lung in 80% cases. Other rare sites were esophagus, mediastinal mass,
thymus and pancreas i.e. 1 case each (Table-7) Metastatic ductal carcinoma of
breast was found in total 6.4% of cases and in females, it was present in
nearly 30% of cases. Although the occurrence of neck metastases in breast
carcinoma is low (2.3% to 4.3%)[10-13], breast cancer is the most common
distant primary to metastasize to neck lymph nodes.12The cervical
nodes most often affected are the supraclavicular lymph nodes; jugular chain
metastases are an extraordinarily rare event (≤0.5% of cases) [14].
Metastatic
papillary carcinoma of thyroid was found in total 2.4% of cases and in females,
it was present in 9% cases. (Table-2,3)El-Foll
HA[15] has done study of 44 cases diagnosed with papillary carcinoma of
thyroid and found nearly 40% cases with neck lymph node metastasis. In view of
this and present study, papillary carcinoma and other malignancy of thyroid are
to be considered in differential diagnosis in metastatic cervical lymph nodes
especially in females.
In any malignancy,
presence or absence of lymph node metastasis is the most significant prognostic
factor in view of management and survival [1]. Cervical lymph nodes are group
of nearly 300 smalls to medium sized lymph nodes present on either side of neck
[16]. They are classified into numeric levels i.e. level I to VI according to
anatomic location of lymph nodes [17]. Cervical lymph nodes drain the head and
neck region and harbour metastasis from regional head and neck SCC i.e. from
oral cavity, pharynx, larynx or facial skin. Left supraclavicular or Virchow’s
lymph nodes are connected to the thoracic duct and are involved in various
tumors located distant to the neck region or tumors located infraclavicular
compartment [17].
Wide range of the
pattern of metastasis to the neck lymph nodes are present. Tumors with known
primary sites of oral cavity and upper aero digestive tracts i.e. pharynx,
larynx are the most common metastatic malignancies found in the neck lymph
nodes [18]. Tumors with known primary site other than oral cavity or upper aero
digestive tract i.e. breast, lung, gastrointestinal tract, thyroid, urogenital
tract, central nervous system, various sarcomas or haematolymphoid malignancies
are found not uncommonly in metastatic neck lymph nodes [2]. Patients with
unknown primary site of tumors are also present commonly with cervical lymph
node metastasis. Most frequent secondary malignancies in cervical lymph nodes
in which primary sites remain unknown are squamous cell carcinoma metastasise
from nasopharynx, oropharynx and hypopharynx [19]. In metastatic adenocarcinoma
to cervical lymph nodes, most common primary site is to be the lung in males
and breast ductal carcinoma in females [11]. Sometimes patients present with
occult metastasis in cervical lymph nodes, in which primary site is not found
even after vigorous search by means of imaging or blind biopsy techniques [20].
Other type of patients with cervical lymph node metastasis are that they
present months or years after successful surgery, chemotherapy or radiotherapy
i.e. recurrence/relapse after cure.
Conclusion
SCC is the most common metastatic malignancy
present in the cervical lymph nodes. SCC spreads from regional Head and Neck
primary sites most commonly but not always. SCC from Lung, Esophagus or Cervix
can also present as metastatic lymph node in Head and Neck and should be
considered as differential diagnosis when primary tumor site not known. In patients
younger than 20 years of age, malignancy other than SCC should always keep in
differential diagnosis like Nasopharyngeal Carcinoma or Haematolymphoid
Malignancy. Not uncommonly, other secondary malignancies like Adenocarcinoma
and Neuroendocrine carcinoma from Lung or GI Tract in Males & Ductal
Carcinoma of Breast and Papillary Thyroid Carcinoma in Females can also involve
Neck Lymph nodes. Regional metastasis is more frequent in Level-II, III and
distant metastasis is present predominantly in Supraclavicular Lymph nodes.
Contribution by Authors
(1) Dr. Siddharth, Resident Doctor has
collected all the samples, examined and interpreted all the smears and slides
and corresponded with Journal Editors.
(2) Dr. Dhaval as Senior Consultant and PG
Guide, supervised and guided him in all steps and improved at his best.
What
this study adds to existing Knowledge: We hope, this study will helpthe pathologists to know the incidence of
various metastatic malignancies in cervical nodes&clinicians to know the
probable primary site origin in case of metastasis of unknown origin in
cervical lymph nodes.
Abbreviations
AOM- Angle of Mouth
BM- Buccal Mucosa
BOT- Base of Tongue
FNAC- Fine Needle Aspiration
Cytology
IHC- Immunohistochemistry
LN- Lymph Node
PNET- Primitive
Neuroectodermal Tumor
RCC- Renal Cell Carcinoma
SCC- Squamous Cell Carcinoma
References
How to cite this article?
Jetly D, Thummar S. Pattern of Metastasis in Cervical Lymph Nodes and Topographic Distribution of Primary Site: Study of 375 Cases. Trop J Path Micro 2019;5(3):137-143.doi:10.17511/jopm.2019.i3.05.